Utama › Glioma › Texas › Houston
Kajian klinikal Glioma di Houston, TX
23 kajian untuk Glioma sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Mengambil pesertaFasa 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Mengambil pesertaFasa 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Mengambil pesertaFasa 1
- M D Anderson Cancer Center, Houston
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Mengambil peserta
- M D Anderson Cancer Center, Houston
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
Mengambil pesertaKajian pemerhatian
- M D Anderson Cancer Center, Houston
Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Mengambil pesertaFasa 1
- The University of Texas M. D. Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Mengambil pesertaKajian pemerhatian
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Mengambil pesertaFasa 3
- MD Anderson Cancer Center, Houston
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Mengambil pesertaKajian pemerhatian
- M D Anderson Cancer Center, Houston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Research Site, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Mengambil pesertaFasa 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Mengambil pesertaFasa 1
- Texas Children's Hospital, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- University of Texas MD Anderson Cancer Center, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Texas Children's Hospital, Houston
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
Mengambil pesertaFasa awal 1
- M D Anderson Cancer Center, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Mengambil pesertaFasa awal 1
- Texas Children's Hospital, Houston
Kajian Glioma di bandar lain
- New York City, NY25 kajian
- Boston, MA20 kajian
- Washington, DC19 kajian
- Philadelphia, PA16 kajian
- Miami, FL15 kajian
- Columbus, OH15 kajian
- San Francisco, CA14 kajian
- Chicago, IL13 kajian
- Durham, NC12 kajian
- Seattle, WA11 kajian
- Los Angeles, CA10 kajian
- St. Louis, MO10 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.